I

iBio
D

IBIO

0.99370
USD
-0.03
(-2.58%)
مغلق
حجم التداول
6,266
الربح لكل سهم
-2
العائد الربحي
-
P/E
1
حجم السوق
10,006,559
أصول ذات صلة
A
ALT
0.61000
(11.82%)
5.77000 USD
A
AMRN
0.000
(0.00%)
10.990 USD
A
AXSM
-0.050
(-0.04%)
112.190 USD
E
EVOK
0.18000
(6.19%)
3.09000 USD
I
INO
0.03000
(1.59%)
1.91500 USD
T
TTNP
-0.01000
(-0.27%)
3.75000 USD
V
VSTM
0.02000
(0.27%)
7.43000 USD
X
XENE
0.210
(0.55%)
38.310 USD
المزيد
الأخبار المقالات

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.